title: Human parechovirus 1 utilizes integrins alphavbeta3 and alphavbeta1 as receptors.
abstract: Human parechovirus 1 (HPEV1) displays an arginine-glycine-aspartic acid (RGD) motif in the VP1 capsid protein, suggesting integrins as candidate receptors for HPEV1. A panel of monoclonal antibodies (MAbs) specific for integrins alphavbeta3, alphavbeta1, and alphavbeta5, which have the ability to recognize the RGD motif, and also a MAb specific for integrin alpha2beta1, an integrin that does not recognize the RGD motif, were tested on A549 cells. Our results showed that integrin alphav-specific MAb reduced infectivity by 85%. To specify which alphav integrins the virus utilizes, we tested MAbs specific to integrins alphavbeta3 and alphavbeta1 which reduced infectivity significantly, while a MAb specific for integrin alphavbeta5, as well as the MAb specific for alpha2beta1, showed no reduction. When a combination of MAbs specific for integrins alphavbeta3 and alphavbeta1 were used, virus infectivity was almost completely inhibited; this shows that integrins alphavbeta3 and alphavbeta1 are utilized by the virus. We therefore proceeded to test whether alphav integrins' natural ligands fibronectin and vitronectin had an effect on HPEV1 infectivity. We found that vitronectin reduced significantly HPEV1 infectivity, whereas a combination of vitronectin and fibronectin abolished infection. To verify the use of integrins alphavbeta3 and alphavbeta1 as HPEV1 receptors, CHO cells transfected and expressing either integrin alphavbeta3 or integrin alphavbeta1 were used. It was shown that the virus could successfully infect these cells. However, in immunoprecipitation experiments using HPEV1 virions and allowing the virus to bind to solubilized A549 cell extract, we isolated and confirmed by Western blotting the alphavbeta3 heterodimer. In conclusion, we found that HPEV1 utilises both integrin alphavbeta3 and alphavbeta1 as receptors; however, in cells that express both integrins, HPEV1 may preferentially bind integrin alphavbeta3.
authors.affiliation: Department of Biological Sciences, University of Essex, Colchester, United Kingdom. ktrian@essex.ac.uk
authors.forename: K
authors.initials: K
authors.lastname: Triantafilou
authors.forename: M
authors.initials: M
authors.lastname: Triantafilou
authors.forename: Y
authors.initials: Y
authors.lastname: Takada
authors.forename: N
authors.initials: N
authors.lastname: Fernandez
mesh_terms: D000818:Animals; D016466:CHO Cells; D006224:Cricetinae; D005353:Fibronectins / Q000378:metabolism; D006801:Humans; D016023:Integrins / Q000235:genetics / Q000378:metabolism*; D008024:Ligands; D010849:Picornaviridae / Q000378:metabolism* / Q000502:physiology; D011991:Receptors, Virus / Q000378:metabolism*; D019030:Receptors, Vitronectin / Q000235:genetics / Q000378:metabolism*; D014407:Tumor Cells, Cultured; D010948:Viral Plaque Assay; D019096:Vitronectin / Q000378:metabolism
chemical_list: D005353:Fibronectins; D016023:Integrins; D008024:Ligands; D011991:Receptors, Virus; D019030:Receptors, Vitronectin; D019096:Vitronectin; C094340:integrin alphavbeta1